Word

KAYLUNRIE

Status

Dead

Status Code

606

Status Date

Monday, September 11, 2023

Serial Number

97240191

Mark Type

4000

Filing Date

Wednesday, January 26, 2022

Published for Opposition

Tuesday, December 13, 2022

Abandoned Date

Monday, September 11, 2023

Trademark Owner History

Eli Lilly and Company - Owner At Publication

Classifications

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Trademark Events

Sep 11, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Sep 11, 2023

Abandonment - No Use Statement Filed

Feb 7, 2023

Noa E-Mailed - Sou Required From Applicant

Dec 13, 2022

Official Gazette Publication Confirmation E-Mailed

Dec 13, 2022

Published For Opposition

Nov 23, 2022

Notification Of Notice Of Publication E-Mailed

Nov 8, 2022

Approved For Pub - Principal Register

Nov 4, 2022

Assigned To Examiner

Jan 31, 2022

New Application Office Supplied Data Entered

Jan 29, 2022

New Application Entered